Daytime somnolence and night sleep disturbances in Parkinson's disease: Background and future treatment prospective

Angelo Antonini

Research output: Contribution to journalArticlepeer-review

Abstract

Sleep abnormalities are common in patients with Parkinson's disease (PD). Current clinical evidence suggests that both daytime somnolence and night-time sleep abnormalities are related mainly to worsening disease. Improvements in drug delivery, such as transdermal patch, allow more stable dopaminergic stimulation throughout the day. This approach might prove beneficial also for nonmotor symptoms and particularly helpful in improving sleep architecture in PD.

Original languageEnglish
JournalNeurological Sciences
Volume28
Issue numberSUPL.1
DOIs
Publication statusPublished - Jan 2007

Keywords

  • Daytime somnolence
  • Dopaminergic treatment
  • Parkinson's disease
  • Sleep abnormalities

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Daytime somnolence and night sleep disturbances in Parkinson's disease: Background and future treatment prospective'. Together they form a unique fingerprint.

Cite this